OptimizeRx Reports First Quarter 2020 Results; Revenue Up 46% to a Record $7.6 Million
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Optimizerx Corporation (OPRX) Misses Q1 EPS by 3c, Revenues Beat
May 4, 2020 4:40 PM EDTOptimizerx Corporation (NASDAQ: OPRX) reported Q1 EPS of ($0.06), $0.03 worse than the analyst estimate of ($0.03). Revenue for the quarter came in at $7.6 million versus the consensus estimate of $6.89 million.
Q1 2020 Financial Highlights
Total year over year revenue increased 46% to a record $7.6 million.Year over year gross profit increased 20% to $4.3 million.Cash and cash equivalents totaled $15.2 million at March 31, 2020.Q1 2020 Operational Highlights
Secured several multi-million-dollar enterprise-level engagements for access to OptimizeRxs fully integrated communications platform, further transitioning the company to a recurring revenue model. OptimizeRx Innovation Lab launched... More